Page 1 of Clinical Trials for iOMEDICO AG [SPONSOR-COLLABORATORS], 17 Total Matches
- 1RecruitingLast Updated: March 12, 2012Condition(s): Renal Cell Carcinoma
- 2RecruitingLast Updated: March 12, 2012Condition(s): Metastatic Breast Cancer
- 3Active, not recruitingLast Updated: May 16, 2012Condition(s): Multiple Myeloma
- 4RecruitingLast Updated: February 1, 2012Condition(s): Locally Advanced and/or Metastatic Renal Cell Carcinoma; Carcinoma, Renal Cell; Clear-cell Metastatic Renal Cell Carcinoma
- 5Recruiting
- 6RecruitingLast Updated: March 12, 2012Condition(s): Observational Study; Registry
- 7Completed
- 8RecruitingLast Updated: May 16, 2012Condition(s): Metastatic Renal Cell Carcinoma; Patients Who Have Progressed on or After the First VEGF-targeted Therapy
- 9RecruitingLast Updated: May 16, 2012Condition(s): MDS; AML; CMMOL
- 10Recruiting
- 11RecruitingLast Updated: March 12, 2012Condition(s): Malignant Lymphatic Diseases
- 12Active, not recruitingLast Updated: June 7, 2011Condition(s): Non Small Cell Lung Carcinoma; Metastatic Breast Cancer
- 13RecruitingLast Updated: August 26, 2011Condition(s): Metastatic Breast Cancer
- 14Active, not recruitingLast Updated: March 9, 2012Condition(s): Renal Cell Carcinoma
- 15Active, not recruitingLast Updated: November 11, 2011Condition(s): Colorectal Neoplasms
- 16RecruitingLast Updated: November 9, 2010Condition(s): Metastatic Breast Cancer; HER2 Positive; First or Second Line Therapy; Failure or Contraindication of Trastuzumab Therapy
- 17RecruitingLast Updated: March 9, 2012Condition(s): Head and Neck Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=iOMEDICO+AG
